BioSpace News Archive

Wilmington, Delaware, United States: Retail clinics are the ones that provide primary healthcare services across departmental stores, supermarkets, and retail stores.

Sweden-based NorthX Biologics (“NorthX”), which focuses on process development and GMP manufacture of advanced biological drugs, has announced the appointments of Lotta Ljungqvist, Richard Bergström, Mathias Uhlén and Lars Backsell to its board of directors.

Vyluma, Inc. (“Vyluma”), a biopharmaceutical company developing multiple assets in the ophthalmic space for the treatment of refractive errors, and Laboratoires Théa (“Théa”) announced that they have recently entered into an exclusive licensing agreement for the registration and commercialization of NVK002 in Canada, Mexico, and select South American Countries.

Day One Biopharmaceuticals, Inc. (Nasdaq: DAWN), a clinical-stage biopharmaceutical company dedicated to developing and commercializing targeted therapies for people of all ages with life-threatening diseases, today announced that it has commenced an underwritten public offering of $125.0 million of shares of its common stock.

Actinogen Medical Limited recently announced positive results for Part A of its two-part double-blind placebo-controlled XanaMIA dose-ranging trial, which confirmed Xanamem’s ability to rapidly enhance attention and working memory.

KBI Biopharma SA and Selexis SA, both JSR Life Sciences companies, announced that an expanded, fully-integrated mammalian contract development and manufacturing services facility is now open and operational in Geneva, Switzerland.

Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), today announced that three composition of matter patents for GTX-104 were issued by The United States Patent and Trademark Office, the Japanese Patent Office, and the Australian Patent Office.

Remington Medical, a medical device manufacturing company based in the U.S., announced the launch of VascuChek®, the industry’s first modern wireless, handheld vascular Doppler device for surgical and clinical use.

ValGenesis, Inc. has acquired Portugal-based 4Tune Engineering, a leader in manufacturing sciences and technologies that enable the world’s most successful life sciences companies to model their risk management programs and improve process performance across the entire GMP lifecycle.

Aural Analytics, Inc. , a leader in clinical-grade speech analytics, announced today a partnership with Koneksa , a leader in digital biomarker development, to further strengthen its platform and research capabilities using Aural Analytics’ technology, Speech Vitals.